BioAge Labs, Inc.
BIOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $211 | $148 | $135 | $208 |
| - Cash | $216 | $220 | $257 | $354 |
| + Debt | $7 | $9 | $10 | $9 |
| Enterprise Value | $2 | -$64 | -$112 | -$138 |
| Revenue | $2 | $2 | $1 | $0 |
| % Growth | -14.8% | 66.2% | – | – |
| Gross Profit | $2 | $2 | $1 | $0 |
| % Margin | 100% | 100% | 100% | – |
| EBITDA | -$20 | -$21 | -$13 | -$21 |
| % Margin | -972.4% | -883.3% | -870.8% | – |
| Net Income | -$20 | -$22 | -$13 | -$21 |
| % Margin | -982% | -894% | -891% | – |
| EPS Diluted | -0.56 | -0.6 | -0.36 | -1.97 |
| % Growth | 6.7% | -66.7% | 81.7% | – |
| Operating Cash Flow | -$16 | -$20 | -$17 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$16 | -$20 | -$18 | -$5 |